ABSTRACT. Inotropic support with digoxin is commonly used in patients with left ventricular volume overload due to ventricular septal defect (VSD). However, the hemodynamic consequences of inotropic agents with VSD have not been experimentally explored. We studied two inotropic agents, digoxin and amrinone, in chronically instrumented lambs with left ventricular volume overload due to a surgically created VSD. Intravenous digoxin (40 &kg) produced serum levels of 3.5 f 0.9 ng/ml (mean -C S D ) in seven lambs 60 min after administration, reduced the heart rate by 16% (172 to 149 beats/min, p < 0.05), increased the stroke volume 16% (29.8 to 34.5 mllbeat, p < 0.05) but did not significantly alterthe systemic flow index (Q,), the pulmonary flow index (Q,), or the volume of left to right shunt (QLR, 6.74 to 6.77 liter/min/m2). The mean left atrial pressure (LA) was unchanged (17.6 versus 17.1 mm Hg) following digoxin. Chronic digoxin use in four lambs for 4 days (25 f 8 &kg/8 h) produced trough serum levels of 1.2 ? 0.2 ng/ml. There was no additional hemodynamic effect compared to acute digoxin, the Q,/Q, ratio was unchanged (3.10 versus 3.08) and evidence of left ventricular volume overload (LA -14.0 versus 13.4) was unchanged. Amrinone lowered the systemic resistance index in a dose dependent fashion. The peak reduction of 20% (25.3 to 20.3 U/m2, p < 0.01) occurred a t 20 min after an intravenous (3 mg/kg) bolus in seven lambs. The Q, increased from 2.58 to 3.10 litef/min/m2 ( p < 0.01). The Q, was unchanged, thus the Q,/Q, ratio was lowered by 16% (p < 0.05). Amrinone caused a 17% reduction in LA (17.9 to 14.9, p < 0.05) and increased the heart rate by 7%. The 
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The absence of controlled clinical studies demonstrating digoxin efficacy with VSD and reports of therapeutic failure of digoxin in some infants (6, 7) has caused the use of digitah preparations with left to right shunts to be questioned (8). PL recent clinical study of VSD found that 50% showed improvement following digoxin (9) . Failure of medical management with digoxin and diuretics has led to early surgical correction despite the observation that the majority of ventricular septal defects will either diminish in size or close spontaneously with growth of the child (10, 11).
Vasodilating agents have been shown to be helpful in patient:; with volume overload of the left ventricle due to mitral (12) oir aortic (13) insufficiency or VSD (14) . Experimental studies have also shown hemodynamic improvement with VSD (15, 16) oiaortocaval fistula ( 1 7) following vasodilators. With an aortocaval fistula and left ventricular volume overload nitroprusside was effective at decreasing evidence of volume overload while digoxin was not (1 7).
Amrinone is a new inotropic agent which also has direct peripheral vasodilating properties (18, 19) . Digoxin either ha:; little effect or may actually increase arterial and venous tone (20) . We evaluated the hemodynamic effects of inotropic support in a chronic, nonsedated, instrumented lamb model with VSE) and left ventricular volume overload. Since vasodilators are useful with VSD (14-16) we studied the hemodynamic change:; following acute and chronic digoxin and those following amrinone.
METHODS
The details for creating the VSD in lambs and subsequenit instrumentation have been previously published (16) . Basically, lambs (approximately 2 wk old) were anesthetized with ketaminc: and a Teflon grommet was placed zcross the interventricular septum through a right atriotomy. The defects were 8 mm in internal diameter and resulted in indexed pulmonary to systemic blood flow ratios (Q,/Q,) greater than 3 to 1. After a 1-WE: recovery period, the lambs were instrumented with aortic and pulmonary artery electromagnetic flow probes (Biotronix Inc.). Indwelling catheters were inserted into the left atrium, right atrium, pulmonary artery, and aorta. The animals were again allowed to recover for at least 1 wk prior to data collection. All the lambs were spontaneously active, feeding, and had normal arterial blood gasses after the recovery period. The total group of 1 1 lambs used to study digoxin was not the exact same group of nine lambs used for amrinone studies since there was occasionally loss of catheters or flow probe malfunction between studies.
DRUG ADMINISTRATION
Only one drug was administered on a given day and, following digoxin use, at east 72 h elapsed prior to any subsequent drug trials which allowed for clearance of digoxin. The lambs were studied while standing quietly in a supporting cradle after a 30-min stabilization period. Amrinone was dissolved in a lactic acidascorbic acid solution and was diluted and filtered through a 0.45 fi Millipore filter prior to use. In three lambs the dose response to amrinone was determined. The dose causing maximal systemic vasodilation (3 mg/kg) was then given to each lamb with data recorded at 10-min intervals for a total of 60 min. Sham infusions with the amrinone vehicle were also performed. Complete hemodynamic measurements were available from seven lambs and flow variables were available in two additional animals with amrinone.
Digoxin was obtained from the hospital pharmacy as the injectable preparation. Each lamb was given a dose of 40 ~g / k g as a slow intravenous bolus. The electrocardiogram was continuously monitored. Data were recorded at 15-min intervals over a total period of 120 min. Complete hemodynamic data were available in seven lambs with digoxin. Subsequently, digoxin was continued for 4 days with daily observations in four additional lambs. Following the loading dose digoxin was administered intravenously every 8 h to maintain the trough serum concentration greater than 1 ng/ml. 
DATA REDUCTION
Flow and resistance data were indexed to the body surface area (16) . Data following drug administration were compared to control data obtained immediately prior to drug use and after the lamb had stabilized. Data for each point included the Q,, the Q,, phasic and mean aortic, pulmonary artery and left atrial pressures. The heart rate was recorded continuously. Resistance data were calculated by dividing the appropriate mean arterial pressure by the flow (1 6) and are expressed without units.
Diaoxin levels were ~erformed in the clinical lab using a
STATISTICAL METHODS
The data were evaluated statistically using analysis of variance and Dunnet's method for comparing sequential posttreatment values with the control (22) . The Student's t test with the Bonferroni adjustment of critical values was used for analyzing the single point data obtained at the time of peak drug effect.
RESULTS
Amrinone. Amrinone produced a dose (0.1 to 4.0 mg/kg) dependent decrease in R, with maximum effect occumng at approximately 3 mg/kg (Fig. 1) . Doses up to 1 mg/kg did not change the R,,. A dose greater than 1 mg/kg reduced R,, slightly although the change was not significant.
Amrinone (3 mg/kg) was administered to nine lambs by bolus injection and in seven complete hemodynamic data were available (Table 1) . Within 10 min there was a 16% reduction (25.3 to 20.8 U) in the R,. The Q, increased 20% (2.58 to 3.08 liter/ min/m2) without a significant change in the Q, (Fig. 1) . Thus, the iZ,/Q, ratio decreased 17% (3.65 to 3.04, p < 0.05). Peak effect occurred at 20 min when the R, was decreased by 20%. The R, was unchanged (1.41 to 1.46 U/m2) and the R,/R, ratio (Table 1) increased by 27% (0.055 to 0.07, p < 0.05). The Qp/Q, ratio was lowered by 16%. The hemodynamic changes persisted for approximately 30 min and slowly returned toward control values by 60 min (Fig. 2) . The also returned toward control values by 60 min. The stroke volume was unchanged (Table 1) . With sham drug administration the amrinone vehicle alone did not significantly alter any observed parameter or the arterial blood gas.
Digoxin. Following an intravenous bolus of digoxin (40 fig/   kg ) in seven lambs, a serum level of 3.5 k 0.9 ng/ml (mean + SD) was obtained at 60 min. Digoxin effect (Table I ) was demonstrated by a reduction in heart rate (172 to 149, p < 0.05) and an increase in SV from 30 to 35 ml/beat ( p < 0.05).
However, none of the flow parameters (Q,, Q,, Qp/Q,) were significantly altered (Fig. 3) . The left to right shunt volume was unchanged (6.73 to 6.77 liter/min/m2). Digoxin did not significantly affect aortic or pulmonary artery pressures or resistances. Furthermore, the left atrial pressure was unchanged (17.7 versus 17.1 mm Hg, Fig. 4 ). The pattern of response persisted during the 2-h observation period (Fig. 3) .
Digoxin was then administered chronically for 4 days to four instrumented lambs. Digoxin was given intravenously every 8 h to maintain a trough serum digoxin concentration greater than 1 ng/ml. The mean dose was 25 + 8 pg/kg/8 h, and the mean trough serum digoxin concentration on day 4 was 1.2 + 0.2 ng,/ ml. Using a single compartment model the half-life of digoxin with chronic therapy was approximately 15 h with an elimination constant of 0.04581h. The pattern of response for chronic digoxin was identical to acute digoxin (Fig. 5) . There was no significant effect on any of the flow, pressure, or resistance parameters.
There was a significant reduction in heart rate (173 + 29 to 144 + 30, p < 0.05) and the stroke volume increased (28.3 + 7.3 to 32.1 + 9.2). In five control instrumented lambs there was no significant change in any hemodynamic variable over a 4-day observation period (Table 2) . DISCUSSION The role of depressed myocardial function with left ventricular volume overload due to left to right shunts such as VSD remains controversial (8). Inotropic support with digoxin continues to be part of the initial medical management for patients with VSL).
The most severely affected infants often fail to respond satisfactorily and require surgery in infancy. Optimizing medical management may allow the child to grow to a size which lessens the surgical risk (23) or may allow for spontaneous closure of the defect in some (10, 1 I) .
The experimental evaluation of digoxin in the presence of left ventricular volume overload from VSD has not been previously reported. To explore the hemodynamic effects of digoxin we studied nonsedated, unanesthetized lambs with a surgically created VSD. Since the effects of right ventricular communication on estimates of left ventricular function are unknown we indirectly assessed the response to pharmacologic inotropic support by measuring hemodynamic variables. If changes in the inotropic state were critical to the pathophysiologic hemodynamic state with VSD then alterations in the inotropic state should be reflected in hemodynamic measurements.
Digoxin did not significantly alter in seven acutely and four chronically studied lambs any of the abnormal hemodynamic parameters associated with VSD found in this model. Serum digoxin levels were in the therapeutic range and digoxin effect was demonstrated by slowing of the heart rate. In addition, the increase in stroke volume, despite an unchanged LA (estimate of preload), and an unchanged R, or R,, (estimates of afterload) would support an inotropic effect of digoxin. Despite this evidence of digoxin effect the various flow, pressure, or resistance hemodynamic variables were unchanged. Since digoxin does not have a selective vascular action (20) it is not unexpected that the Q,/Q, ratio was unchanged. However, if depressed myocardial function was important in the development of left ventricular volume overload one might anticipate changes in the loading characteristics of the left ventricle following digoxin for the same left to right shunt. We did not observe a significant change in mean left atrial pressure with digoxin. The fact that digoxin did not decrease left atrial hypertension is important because this hemodynamic variable may most closely correlate to clinical symptoms of pulmonary congestion and may be related to the development of pulmonary hypertension (6).
The clinical impression of digoxin effectiveness in some patients may represent a subset in whom myocardial dysfunction contributes to symptoms (9) or may relate to other effects of digoxin such as on the central nervous system (24) or kidney (25) . In fact, in children with VSD the clinical assessment of digoxin effect did not necessarily correlate with echocardiographic estimates of inotropic response (9) . The ability to increase cardiac output by increasing heart rate represents a form of cardiovascular reserve. If the heart rate is decreased and cardiac output maintained following digoxin it may be that a portion of heart rate reserve has been regained. The reduction in heart rate noted in this study was seen in both acute and chronic digoxin. The increased heart rate reserve may contribute to the clinical impression of digoxin effect.
Fetal lambs have been shown to be less sensitive to both the toxic and inotropic effects of digoxin compared to ewes, despite similar tissue-plasma ratios (26) . A possible explanation for the lower inotropic response may be that the newborn lamb myocardium functions closer to the maximum inotropic state than the adult (27) and, thus, is less sensitive in terms of percentage change to inotropic stimulation. The data from this study were collected on lambs approximately 4 to 6 wk old which would more closely approximate the adult hemodynamic state (28) . Although the acute serum digoxin levels in this study do not represent steady state kinetics with respect to tissue distribution, there was clearly a significant change in heart rate and stroke volume (Fig. 4) by 60 min. Furthermore, chronic administration of digoxin. which would allow for tissue eauilibration, produced beneficial effect of selective systemic vasodilatation on the left to right shunt found with VSD (14) (15) (16) . Amrinone is an inotropic agent with direct systemic vasodilating properties. We studied amrinone and digoxin because of this important difference.
Amrinone was found to favorably alter the abnormal hemodynamics in this model (Fig. 2) . The reduction in R, was accompanied by a reduction in ,Q,/Q, and the was lowered 17% ( p < 0.01, Fig. 4) . As the Q, was not significantly decreased, the reduction in may be due to the decreased afterload (R,) on the left ventricle and/or an inotropic effect of amrinone. The reduction in may be due to the decreased afterload (R,) on the left ventricle and/or an inotropic effect of amrinone. The stroke vo&me was unchanged with amrinone but both the preload (LA) and afterload (R,) were altered and, thus, lack of change in SV cannot be directly interpreted as lack of change in the inotropic state. The reduction in and Q,/Q, and the increased Q, would be beneficial alterations and most likely reflect the change in R,. An inotropic effect alone would not explain the redistribution of flow observed with amrinone, but may contribute to the reduction in i&. Amrinone caused a dosedependent reduction in R, and Q,/Q,. However, the maximum change in Q,/Q, occurred at a lower dose than the maximum change in R, since with increasing amrinone dose a pulmonary vasodilating response was observed, as previously reported (30) . There is also an age-dependent response to amrinone. Isolated canine neonatal myocardium is relatively insensitive to amrinone, but the response matures rapidly with age (31) . In six lambs of a similar age without VSD, we found that amrinone (3 mg/kg) caused an 18% increase in LV dP/dtO (263 1 versus 3 109 mm Hg/s) 30 min after bolus administration indicating that normal lambs of this age are capable of demonstrating an inotropic response to amrinone.
The data show that acute or chronic inotropic support with digoxin at therapeutic serum levels did not significantly change any hemodynamic parameter in a total of 1 I lambs with chronic left ventricular volume overload due to VSD. These data may indicate that a generalized depression in myocardial function does not play a major role in determining the abnormal hemodynamics seen with VSD. There was a reduction in heart rate despite no significant change in systemic flow, thus, digoxin apparently did cause some recovery of heart rate reserve. The change in heart rate with digoxin may be due to its inotropic properties or perhaps via its effects on the autonomic nervous system. Amrinone decreased several important hemodynamic variables found with VSD and a large left to right shunt including systemic resistance, the Q,/Q, ratio, and left atrial hypertension. Despite the reduction in mean left atrial pressure, amrinone increased systemic blood flow without significantly effecting the heart rate. These changes would be hemodynamically beneficial.
